Healthcare DIVE February 28, 2018
Dive Brief:
- Executives from CVS Health and Aetna sought to assure lawmakers that their $69 billion merger would create value for consumers and not result in anti-competitive behavior. They spoke at a hearing before the House Judiciary Regulatory Reform, Commercial and Antitrust Law Subcommittee on Tuesday.
- The hearing comes as the American Medical Association urged Congress to “closely scrutinize the pending merger deal,” worried that it could reduce competition among pharmacy benefit managers, local health insurance markets and local retail pharmacy markets.
- Lawmakers queried the officials, but did not appear to oppose the merger outright.
Dive Insight:
Lawmakers on both sides of the aisle pressed top lawyers from the companies for a commitment to not act in anti-competitive...
Today's Sponsors
Today's Sponsor